Results 111 to 120 of about 3,606,010 (253)

EAM conditioning regimen followed by autologous hematopoietic Stem Cell Transplantation for relapsed, refractory and high risk lymphomas

Mediterranean Journal of Hematology and Infectious Diseases, 2014
Hematopoietic Stem Cell Transplant is the  standard  treatment of refractory / recurrent lymphomas, most of conditioning regimens in this cases are BCNU-based as for BEAM & CBV , this agent (BCNU) is well-known for its severe lung toxicity .
Mohamed BEKADJA, Tamim ALSULIMAN, Rachid BOUHASS, Abdessamed ARABI, Mohamed BRAHIMI, Soufi OSMANI, Nabil YAFOUR, Souad TALHI   +7 more
doaj  

Novel Cell-Killing Mechanisms of Hydroxyurea and the Implication toward Combination Therapy for the Treatment of Fungal Infections [PDF]

, 2017
Amanpreet Singh, Ameeta K. Agarwal, Yong-jie Xu   +2 more
openalex   +1 more source

BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy

, 2019
Eric L. Smith, Sham Mailankody, Mette Stæhr, Xiuyan Wang, Brigitte Sénéchal, Terence J. Purdon, Anthony F. Daniyan, Mark B. Geyer, Aaron D. Goldberg, Elena Mead, Bianca Santomasso, Jonathan Landa, Andreas Rimner, Isabelle Rivière, Ola Landgren, Renier J. Brentjens   +15 more
openalex   +2 more sources

Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinoma [PDF]

, 1995
Francisco J. Esteva-Lorenzo, John E. Janik, Robert G. Fenton, Alison M. Emslie‐Smith, Andrew G. Engel, Dan L. Longo   +5 more
openalex   +1 more source

Article Commentary: First Human Myoblast Transfer Therapy Continues to Show Dystrophin after 6 Years

Cell Transplantation, 1997
Peter K. Law Ph.D., Tena G. Goodwin, Qiuwen Fang, Terry L. Hall, Tom Quinley, George Vastagh, Vijaya Duggirala, Charles Larkin, Jerry Ann Florendo, Lawrence Li, Tunja Jackson, T. J. Yoo, Nancy Chase, Michael Neel, Tim Krahn, Randall Holcomb   +15 more
doaj   +1 more source

Photoresponsive Multirole Nanoweapon Camouflaged by Hybrid Cell Membrane Vesicles for Efficient Antibacterial Therapy of Pseudomonas aeruginosa‐Infected Pneumonia and Wound [PDF]

Hening Liu, Lu Tang, Yue Yin, Yuqi Cao, Cong Fu, Jingwen Feng, Yan Shen, Wei Wang   +7 more
openalex   +1 more source

RADIATION THERAPY AS A BRIDGING AND SALVAGE STRATEGY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA UNDERGOING BCMA‐TARGETED CAR T‐CELL THERAPY [PDF]

, 2023
Hazim Ababneh, Albert Yee, Noopur Raje, Scott D. Martin, M. Frigault, Andrea K. Ng, Chirag G. Patel   +6 more
openalex   +1 more source

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial

Haematologica, 2019
Rohtesh S. Mehta, Roland Bassett, Amanda Olson, Julianne Chen, Sairah Ahmed, Amin M. Alousi, Paolo Anderlini, Gheath Al-Atrash, Qaiser Bashir, Stefan O. Ciurea, Chitra M. Hosing, Jin S. Im, Partow Kebriaei, Issa Khouri, David Marin, Jeffrey J. Molldrem, Yago Nieto, Betul Oran, Katayoun Rezvani, Muzaffar H. Qazilbash, Samer A. Srour, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin, Uday R. Popat   +24 more
doaj   +1 more source

A pivotal bridging study of lurbinectedin as second-line therapy in Chinese patients with small cell lung cancer [PDF]

Ying Cheng, Chunjiao Wu, Lin Wu, Jun Zhao, Yanqiu Zhao, Lulu Chen, Ying Xin, Liang Zhang, Pinhua Pan, Xingya Li, Juan Li, Xiaorong Dong, Ke Tang, Emei Gao, Fei Yu   +14 more
openalex   +1 more source

Comparative Analysis of Aptamer-Conjugated Chemical and Green Synthesized Gold Nanoparticles for Targeted Therapy in MCF-7 Cancer Cells [PDF]

Mahmoud Helal, Miftah Faried, S. Ben Salah, Mazen Ashraf, Nada Nasser, Yasser Shawky, Sara Hamdy, Azza El Amir, Wajeet Nabil, Dalia M. El-Husseini   +9 more
openalex   +1 more source